Glaxosmithkline | GSK - Операционный доход

Биржевая цена
52.12
Изменение за день
-7.00 -11.84%
Ежемесячно
-14.35%
Ежегодный
31.78%
Q1 прогноз
52.28




Операционный доход Изменить Дата
AbbVie USD 5.81B 1.23B 2025-12
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Aurora Cannabis CAD -55.67M 35.45M 2025-09
Bausch Health Companies USD 719M 2M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Canopy Growth CAD -14.3M 3.18M 2025-09
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Drreddys Laboratories INR 14.33B 2.51B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Glaxosmithkline GBP 3.76B 1.32B 2025-09
J&J USD 5.59B 1.81B 2025-12
Merck USD 6.24B 318M 2025-12
Novartis USD 4.5B 363M 2025-09
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 82.49M 2.82M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Takeda JPY 168.82B 479.89B 2025-12
Teva Pharmaceutical Industries USD 487M 581M 2025-12
Zoetis USD 835M 101M 2025-12